Your browser doesn't support javascript.
loading
Combined use of amlodipine and folic acid are significantly more efficacious than amlodipine alone in lowering plasma homocysteine and blood pressure among hypertensive patients with hyperhomocysteinemia and intolerance to ACEI: A multicenter, randomized, double-blind, parallel-controlled clinical trial.
Bao, Huihui; Huang, Xiao; Li, Ping; Sheng, Changsheng; Zhang, Jin; Wang, Zhirong; Song, Demin; Hu, Lihua; Ding, Congcong; Cheng, Zaihua; Yao, Chen; Chen, Guangliang; Cui, Yimin; Qin, Xianhui; Tang, Genfu; Wang, Xiaobin; Huo, Yong; Cheng, Xiaoshu; Wang, Jiguang.
Afiliación
  • Bao H; Department of Cardiology, The Second Affiliated Hospital of Nanchang University, Nanchang, China.
  • Huang X; Department of Cardiology, The Second Affiliated Hospital of Nanchang University, Nanchang, China.
  • Li P; Department of Cardiology, The Second Affiliated Hospital of Nanchang University, Nanchang, China.
  • Sheng C; The Shanghai Institute of Hypertension, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China.
  • Zhang J; The Shanghai Institute of Hypertension, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China.
  • Wang Z; Affiliated Hospital of Xuzhou Medical College, Xuzhou, China.
  • Song D; Anqing Municipal Hospital, Anqing, China.
  • Hu L; Department of Cardiology, The Second Affiliated Hospital of Nanchang University, Nanchang, China.
  • Ding C; Department of Cardiology, The Second Affiliated Hospital of Nanchang University, Nanchang, China.
  • Cheng Z; Department of Cardiology, The Second Affiliated Hospital of Nanchang University, Nanchang, China.
  • Yao C; Peking University Clinical Research Institute, Peking University Health Science Center, Beijing, China.
  • Chen G; College of Integrated Chinese and Western Medicine, Anhui University of Chinese Medicine, Hefei, China.
  • Cui Y; Department of Pharmacy, Peking University First Hospital, Beijing, China.
  • Qin X; National Clinical Research Study Center for Kidney Disease, the State Key Laboratory for Organ Failure Research, Renal Division, Nanfang Hospital, Southern Medical University, Guangzhou, China.
  • Tang G; School of Health Administration, Anhui Medical University, Hefei, China.
  • Wang X; Department of Population, Family and Reproductive Health, Johns Hopkins University Bloomberg School of Public Health, Baltimore, Maryland, USA.
  • Huo Y; Department of Cardiology, Peking University First Hospital, Beijing, China.
  • Cheng X; Department of Cardiology, The Second Affiliated Hospital of Nanchang University, Nanchang, China.
  • Wang J; The Shanghai Institute of Hypertension, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China.
J Clin Hypertens (Greenwich) ; 25(8): 689-699, 2023 08.
Article en En | MEDLINE | ID: mdl-37433173
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Hiperhomocisteinemia / Accidente Cerebrovascular / Hipertensión Tipo de estudio: Clinical_trials / Etiology_studies Límite: Humans Idioma: En Revista: J Clin Hypertens (Greenwich) Asunto de la revista: ANGIOLOGIA Año: 2023 Tipo del documento: Article País de afiliación: China Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Hiperhomocisteinemia / Accidente Cerebrovascular / Hipertensión Tipo de estudio: Clinical_trials / Etiology_studies Límite: Humans Idioma: En Revista: J Clin Hypertens (Greenwich) Asunto de la revista: ANGIOLOGIA Año: 2023 Tipo del documento: Article País de afiliación: China Pais de publicación: Estados Unidos